Ted Crandall
Analyst · Jeremie Capron from CLSA
Thanks, Keith. Good morning everybody. I’ll start on page four, second quarter key financial information. Sales in the quarter were $1.551 billion, 3.1% lower than Q2 last year. Organic sales growth was 2.7%, but currency translation reduced sales in the quarter by 6 points. Sales were down about 1.5% sequentially. Sequential organic growth was about 2%, pretty typical in terms of the historic pattern, but currency translation reduced sales by over 3 points sequentially. Segment operating margin continued to be very strong at 21.6%, up 270 basis points from Q2 last year, despite the sales decline. The year-over-year margin increase was primarily due to the higher organic sales, strong productivity and favorable mix, partly offset by some increased spending. I’ll note that Q2 last year is our easiest quarterly margin comparison. General corporate net was $21 million in Q2, up about $2 million compared to a year ago. Still in line with our expectations for the full year. Adjusted earnings per share were $1.59, up $0.24 or 18%, compared to the second quarter of last year. The adjusted effective tax rate in the quarter was 26% compared to 27.9% in Q2 last year. Last year’s rate included some unfavorable prior period adjustments. Free cash flow for Q2 was $269 million, another strong result. Free cash flow conversion on adjusted income was 125% in Q2. Our trailing four quarter return on invested capital was 32%. A couple of items not shown here. Average diluted shares outstanding in the quarter were $136 million, down about 3% compared to last year. Also during the second quarter, we repurchased 1.14 million shares, at a cost of $127 million. Year to date, we’ve repurchased 2.69 million shares at a cost of $294 million. In November we talked about a full year repurchase target of $470 million. We are running about 25% ahead of that pace through March. Similar to last year, it’s likely that we’ll spend above the target for the full year. At the end of the quarter, there was $757 million remaining under our share repurchase authorization. The next two slides present the sales and operating margin performance of each segment, both for the second quarter and year to date. I’ll start with the Architecture & Software segment on page five and I’ll focus my comments on the second quarter results. On the left side of the chart, Architecture & Software segment sales were $674 million in Q2, down 1.8% compared to Q2 last year. Organic growth was 4.8%. We continue to see very attractive growth rates in this segment driven primarily by our Logix platform. Currency translation reduced sales in the quarter by almost 7 points on a year over year basis. Moving to the right side of the chart, on 4.8% organic growth, A&S margins were 29.8%, up 210 basis points compared to Q2 last year, with the improved margin primarily due to higher organic sales and another good productivity quarter. Spending in this segment was up modestly year-to-date through March. We expect spending to increase in the second half. Turning to page 6, this the Control Products and Solutions segment. In the second quarter, Control Products and Solutions segment sale were down 4.1% year over year with organic growth of about 1.2%. Currency translation reduced sales by about 5.5 points. Organic growth for product businesses is in the segment was 5%, equally strong to the growth rate seen in Architecture and Software. However, we continue to experience weakness in the Solutions and Services businesses, with organic sales down about 2%. The book-to-bill in Q2 for Solutions and Services was 1.06. This was lower than we expected and consequently we will be reducing our growth expectation for Solutions and Services in the second half compared to the prior guidance. The order shortfall in Solutions and Services was primarily and heavy industry, with about half that coming in oil and gas. CP&S continued to deliver strong operating margins, 15.2% in Q2, up 300 basis points compared to last year. The year over year margin improvement was due to the organic sales growth, continued favorable mix as our product businesses are out growing Solutions and Services, and particularly strong productivity performance in this segment. Moving to the next slide, page 7 provides a geographic breakdown of our sales and shows organic growth results for the quarter and the first half. Again, I'll focus my comments on the second quarter. The organic sale growth was driven largely by the Americas, with Latin America continuing to experiencing the highest percentage growth rate. The U.S was up 3.5%. Growth in automotive and customer industries more than offset declines in oil and gas. Canada was down 11% compared to Q2 last year. As we discussed last quarter, that was not unexpected. Canada is down 1.7% year to date and we are expecting to be down above mid-single digits for the full year. Canada has a disproportionate exposure to oil and gas and declines there are more than offsetting attractive growth rates in transportation and consumer industries. In Q2 in Latin America, Brazil was about flat year over year, but otherwise growth was pretty broad based across the balance of the region, with Mexico up 18%. Latin America was the only region to experience year over year growth in oil and gas in Q2. EMEA was up 1.2% organically. We saw growth in both mature and emerging EMEA, with a little higher growth in emerging EMEA this quarter. Asia Pacific was up 3.2%, driven primarily by India and China. India was up 16% off of a relatively easy comparison and China was up 6%. As a final note on this slide, overall, emerging market organic growth in Q2 was up over 8%. Please turn to the next page, which is our updated fiscal year 2015 guidance. As Keith mentioned, we are reducing our full year sales guidance but holding the prior EPS range. Across the guidance range, we are reducing sales by about 2.5%. Approximately 1.5% point of that decline is due to currency translation. In our prior guidance, we expected currency transition to reduce full year sales by 4.5%. We now expect currency translation to reduce full year sales by 6% and to reduce full year EPS by about $0.40. We are also reducing sales guidance by 1 point to reflect lower organic growth. The lower organic growth is due in part to lower than expected orders in Q2, primarily in our Solutions and Services businesses. Also, we are now seeing an earlier drop in oil and gas spending than we previously expected. These first two factors are related to some extent. And the last factor, we are continuing to see declines in the forecasts for industrial production growth rates. Our previous guidance called for reported sales of approximately $6.6 billion at the midpoint. We now think the midpoint will be a little over $6.4 billion. The previous guidance called for organic growth of 2.5% to 5.5%. The new guidance is for organic growth of 1.5% to 4.5 %. At the midpoint of sales guidance, we expect year over year organic growth rates in our product businesses to be about the same in the second half as the first half. We expect higher second half growth rates is the Solutions and Services businesses that’s consistent with our backlog and our front log at the end of March. We also expect to see a typically large fourth quarter for sales in our Solutions and Services businesses. Despite the lower sales, we are maintaining the previous EPS guidance ranges of $6.50 to $6.80. We now expect higher margin to offset the earnings impact of reduced sales. The margin improvement compared to prior guidance is based on stronger Q2 margins, a continuation of the strong productivity into the second half and a more favorable earnings conversion on currency translation than we previously expected. We now expect operating margins for the full year to be a little over 21.5%. This margin guidance incorporates an increase in spending in the second half compared to the first half. We continue to expect an adjusted effective tax rate for the full year of 26.5%. Given our strong cash generation though the first six months, we now expect conversion on adjusted income to be above 100% for the full year. There are a few other items not shown here that I think generally are of interest. We continue to expect general corporate net expense to be approximately $80 million for the full year. We continue to expect average diluted shares outstanding to be about $136 million for the full year and finally we are expect process sales growth for the full year to be at above the company average. And with that, I'll turn it back over to Rondi.